Oil Prices Decline as Middle East Tensions Ease 
China's Central Bank Introduces New Lending Tool to Boost Liquidity 
Yara International Reports Strong Q3 Earnings Driven by Record Production 
Japanese Stocks Surge Despite Political Uncertainty Following Election Results 
Boeing Plans $15 Billion Capital Raise Amid Ongoing Strike and Financial Pressures 
Olympus Corp CEO Resigns Amid Drug Allegations, Shares Plummet 
Asian Stocks Climb as Israel-Iran Tensions Ease 
Electrolux Reports Third-Quarter Profit Decline Amid Cost Management Efforts 
Oil Prices Rise Amid Middle East Tensions, Eye Weekly Gains Despite U.S. Inventory Build 
LG Energy Solution Reports 39% Profit Drop Amid Improved Demand from Automakers 
Asian Stocks Stay Flat; Japanese Shares Sink Ahead of Election, Yen Pressure 
Japanese Stocks Rally as Yen Sinks Post-Election, Highlighting Market Uncertainty 
Japan Faces Political Uncertainty After Election Loss for Ruling Coalition 
Asian Currencies Decline Amid Political Uncertainty and Dollar Strength 
Eli Lilly to Introduce Mounjaro Weight-Loss Drug in Hong Kong by Year-End
Global pharmaceutical giant Eli Lilly is gearing up to launch its weight-loss drug, Mounjaro, in Hong Kong by the end of this year. According to a report from Bloomberg News, the company has received approval from Hong Kong's government to sell its tirzepatide injections under the Mounjaro brand.
Mounjaro for Weight Management and Diabetes
Eli Lilly's Mounjaro is designed for both long-term weight management and the treatment of type 2 diabetes. It will be available on the Kwikpen device, which allows for easy self-administration. The company aims to address the growing demand for effective weight-loss treatments while continuing to provide solutions for diabetes management.
Hong Kong Market Entry
Hong Kong marks a strategic entry point for Eli Lilly as it expands its global presence. With the approval of Mounjaro, the company is poised to offer a highly anticipated solution for individuals struggling with obesity and related health issues. The weight-loss sector has seen significant growth in recent years, and Mounjaro is expected to make a notable impact.
